(Q38299500)

1 September 2017

title

Arylisothiocyanate-containing esters of caffeic acid designed as affinity ligands for HIV-1 integrase (English)

1 reference

1 September 2017

Zhang X

1

1 reference

1 September 2017

Neamati N

2

1 reference

1 September 2017

Lee YK

3

1 reference

1 September 2017

Orr A

4

1 reference

1 September 2017

Brown RD

5

1 reference

1 September 2017

Whitaker N

6

1 reference

1 September 2017

Pommier Y

7

1 reference

1 September 2017

Burke TR Jr

8

1 reference

1 September 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

Bioorganic & Medicinal Chemistry

1 September 2017

published in

1 reference

1 September 2017

volume

9

1 reference

1 September 2017

issue

7

1 reference

1 September 2017

page(s)

1649-1657

1 reference

Toward improved anti-HIV chemotherapy: therapeutic strategies for intervention with HIV infections

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900075-X

7 January 2021

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900075-X

7 January 2021

Inhibitors of human immunodeficiency virus integrase.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900075-X

7 January 2021

Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900075-X

7 January 2021

Selective chemical modification of proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900075-X

7 January 2021

Probes for narcotic receptor mediated phenomena. 7. Synthesis and pharmacological properties of irreversible ligands specific for .mu. or .delta. opiate receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900075-X

7 January 2021

Heterogeneity of Benzodiazepine Receptors in the Central Nervous System Demonstrated with Kenazepine, an Alkylating Benzodiazepine

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900075-X

7 January 2021

Preparation of aryl isothiocyanates via protected phenylthiocarbamates and application to the synthesis of caffeic acid (4-isothiocyanato)phenyl ester

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900075-X

7 January 2021

Antiparasitic agents. 5. Synthesis and anthelmintic activities of novel 2-heteroaromatic-substituted isothiocyanatobenzoxazoles and benzothiazoles

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900075-X

7 January 2021

Synthesis of N-hydroxythiourea

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900075-X

7 January 2021

Hydroxylated aromatic inhibitors of HIV-1 integrase

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900075-X

7 January 2021

Reduction and fluorescent labeling of cyst(e)ine-containing proteins for subsequent structural analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900075-X

7 January 2021

Divalent cations stimulate preferential recognition of a viral DNA end by HIV-1 integrase

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900075-X

7 January 2021

Purification of untagged retroviral integrases by immobilized metal ion affinity chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900075-X

7 January 2021

10.1016/S0968-0896(01)00075-X

Identifiers

DOI

1 reference

1 September 2017

1 reference